# The Costs of Drugs Used to Treat Myelodysplastic Syndromes Following National Comprehensive Cancer Network Guidelines

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-costs-of-drugs-used-to-treat-myelodysplastic-syndromes-following-national/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Peter L. Greenberg,Leon E. Cosler,Salvatore Ferro,Gary H. Lyman |
| Citations | 46 |
| DOI | 10.6004/jnccn.2008.0072 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1855038159 |
| PMID | 18926103 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Salvatore Ferro](https://scholariq.org/researchers/salvatore-ferro/)

## Paper journal

- [Journal of the National Comprehensive Cancer Network](https://scholariq.org/journals/journal-of-the-national-comprehensive-cancer-network/)

## Paper primary topic

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)

## Paper topics

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.